Clinical Trials
71 trialsCAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies
AO GENERIUM
The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1
Zhejiang University
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
Celon Pharma SA
MAST
University Health Network, Toronto
ANZUP2001
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
URODETECT-WP1
Novosanis NV
IMMUNOs-SBRT
Centre Georges Francois Leclerc
Patient-Derived Xenografts to Reduce Cancer Health Disparities
University of California, Davis
CAT_PB
Lebanese University
MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers
Peking Union Medical College Hospital
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
Evaluation of Length and Quality of Prostate Biopsies Taken by a New Biopsy Needle
Region Skane
Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients
Angiodynamics, Inc.
MyProstateScore Equivalency With and Without DRE
LynxDx
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Wuhan Ammunition Life-tech Co., Ltd
RESTORE
Blue Note Therapeutics
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
MICROBIOME
Imperial College London
BENEFIT-CA
Hospital de Clinicas de Porto Alegre
VALIDATE-PRO
University College, London
PASSION
Assistance Publique - Hôpitaux de Paris
Efficacy of Durvalumab in Non-muscle-invasive Bladder Cancer
Hellenic GenitoUrinary Cancer Group
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
South East Technological University
68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical
British Columbia Cancer Agency
SCHS
Duke-NUS Graduate Medical School
SOROCOV
Butantan Institute
DWI in the Diagnosis of Histological Types of Nephroblastoma in Children
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
PIONEER
SpeciCare
MindGAP-P
Instituto Portugues de Oncologia, Francisco Gentil, Porto
PSMA-PROSTAPET
Azienda Ospedaliero-Universitaria di Modena
TRACERxRenal
Royal Marsden NHS Foundation Trust
A First-in-Human Study of alpha1H in Patients With Non-muscle Invasive Bladder Cancer
Hamlet Pharma AB
INTERVAL
Guy's and St Thomas' NHS Foundation Trust
Evaluation of Post-operative Biochemical Recurrence in Patients Submitted to Radical Prostatectomy Under General Opioid-free Anesthesia Compared to Conventional General Anesthesia
Instituto do Cancer do Estado de São Paulo
3D-Conformal Radiation vs Helical Tomotherapy in Prostate Cancer
Ottawa Hospital Research Institute
ICI-DISCOVER
Università Politecnica delle Marche
Collaborative Wilms Tumour Africa Project
Amsterdam UMC, location VUmc
Epigenetic and Genetic Effects in Cancer Patients: Analysis Pre and After Treatment
IVI Barcelona
The Importance of Muscle Function in Patients With Disseminated Bladder Cancer
Rigshospitalet, Denmark
ARTIST_RCC
Cambridge University Hospitals NHS Foundation Trust
SetPace
SonaCare Medical
CRPC-PN
Tianjin Medical University Second Hospital
Intensity Modulated Versus Interstitial - Radiation Therapy
British Columbia Cancer Agency
A Study Evaluating MM-310 in Patients With Solid Tumors
Merrimack Pharmaceuticals
A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)
Mansoura University
Influence of Immune Nutrition Diet on 90-Day Outcomes in Patients Undergoing Radical Cystectomy
Mansoura University
Retrospective Study in Patients With Metastatic Renal Cancer Treated With TKI Sequence (Tyrosine Kinase Inhibitors of VEGFR) - mTOR- Axitinib Inhibitors or Anti-VEGF Antibody -Inhibiteurs mTOR - Axitinib
University Hospital, Strasbourg, France
SPIROCAN
Instituto Nacional de Cancerologia de Mexico
Renal Hypothermia During Partial Nephrectomy
Ottawa Hospital Research Institute